ArticleMayo Clinic proceedings. Innovations, quality & outcomes2021

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker.

Nicholas Y Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.